Bilcare Limited has announced that its board of directors will meet on Friday, 29 May 2026. The primary agenda for the meeting is to consider and approve the audited financial results for the quarter and year ended 31 March 2026. The board will review both standalone and consolidated financial statements during the session.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has closed its trading window. This closure became effective from Wednesday, 01 April 2026. The window will remain closed until 48 hours after the declaration of the audited financial results for the quarter and year ended 31 March 2026.

The company had previously intimated the stock exchanges regarding the closure of the trading window via a letter dated 25 March 2026. Designated persons have been communicated about the closure in line with the company's Code of Conduct.

Meeting Details

The board meeting follows the regulations set by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation regarding the meeting was submitted to the Bombay Stock Exchange Limited on May 22, 2026.

Bilcare Limited has announced key changes to its board composition and committee structure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed that Mrs. Madhuri Vaidya (DIN: 08483512) will cease to hold the position of Independent Director upon completion of her second term at the close of business hours on April 26, 2026. Mrs. Vaidya was initially appointed for her second five-year term effective from April 26, 2021. The Board of Directors and Management expressed their appreciation for her valuable contributions during her tenure as an Independent Director.

In a related development, the Board of Directors, based on recommendations from the Nomination & Remuneration Committee, approved the appointment of Advocate Ashwini Ashok Hasabnis (DIN: 7766525) as an Additional Director in the category of Non-Executive Independent Woman Director. The appointment is for a first term of five consecutive years effective from April 25, 2026, subject to approval by the shareholders. The company confirmed that Advocate Hasabnis has not been debarred from holding the office of Director by any order from SEBI or other authorities. Shareholder approval will be sought through Postal Ballot or General Meeting, with details to be communicated in due course.

Advocate Ashwini Ashok Hasabnis brings over two decades of legal experience to the role. She holds a B.A., LL.B. degree and is enrolled with the Bar Council of Maharashtra and Goa. Her specialization includes civil and consumer law matters, arbitration proceedings, banking and finance-related disputes, and legal documentation. She has served as a legal advisor to corporates and banking institutions, providing guidance on contractual matters, documentation, and regulatory compliance.

The Board has also approved the reconstitution of three key committees effective from April 25, 2026. The Audit Committee will be chaired by Mr. Rajesh Devene (Independent Director), with Adv. Ashwini Hasabnis (Independent Director) and Mr. Shreyans Bhandari as members. The Nomination and Remuneration Committee will also be chaired by Mr. Rajesh Devene, with Ms. Alka Sagar (Independent Director) and Adv. Ashwini Hasabnis (Independent Director) serving as members. The Stakeholders Relationship Committee composition includes Mr. Rajesh Devene as Chairperson (Independent Director), Ms. Alka Sagar (Independent Director), and Mr. Shreyans Bhandari as members.

Director Appointment Details

Board Committee Composition (Effective 25 April 2026)